Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/19327| Title: | Phase I trial of 6-hour infusion of glufosfamide, a new alkylating agent with potentially enhanced selectivity for tumors that overexpress transmembrane glucose transporters: a study of the European Organization for Research and Treatment of Cancer Early Clinical Studies Group |
| Institution and School/Department of submitter: | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής |
| Keywords: | Adult,Aged,Antineoplastic Agents, Alkylating/administration & dosage/*adverse,effects/pharmacokinetics,Dose-Response Relationship, Drug,Drug Administration Schedule,Female,Glucose/analogs & derivatives,Humans,Ifosfamide/analogs & derivatives,Infusions, Intravenous,Male,Middle Aged,Monosaccharide Transport Proteins/biosynthesis/*metabolism,Neoplasms/drug therapy/*metabolism,Phosphoramide Mustards/administration & dosage/*adverse effects/pharmacokinetics |
| URI: | https://olympias.lib.uoi.gr/jspui/handle/123456789/19327 |
| ISSN: | 0732-183X |
| Link: | http://www.ncbi.nlm.nih.gov/pubmed/11032596 |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Briasoulis-2000-phase I trial.pdf | 241.05 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License
